Exit

Quick Hits – Women’s Health Board Review Q & A - Webcast Post-Test

Question Title

* 1. After this session, please rate how your level of confidence changed.

Feel no more confident than before.

Feel a little more confident than before.

Feel somewhat more confident.

Feel more confident than before.

Feel a lot more confident than before.

Question Title

* 2. A 20 year old Gravida 1 patient presents with new onset headache at 28 weeks gestation. Which one of the following approaches is not appropriate:

Perform a detailed history, physical exam with special attention to neurologic exam, blood pressure and urine for protein.

If you find focal neurologic signs and symptoms, order an immediate neurologic consultation with a shielded non-contrast head CT scan.

If you diagnose a migraine headache and she does not respond to sumatriptan administer dihydroergotamine.

If you find her neck is stiff and passive movement painful, order a shielded non-contrast CT scan, and if CT is normal, order a lumbar puncture for spinal fluid analysis.

Question Title

* 3. Cervical cancer causes 7% of all cancer deaths worldwide with 85% occurring in developing countries due to ineffective or absent screening. Which one of these statements is false:

The use of the PAP tests in the US has reduced cervical cancer deaths by 50 % from 1930 to 2012.

Annual cervical cancer screening is no longer recommended for the average risk women of any age.

There are approximately 12 HPV types other than types 16 and 18 that account for 25% of cervical cancers.

HPV types 16 and 18 are the most oncogenic types and are responsible for up to 75% of cervical cancers.

Question Title

* 4. There are 13,000 new cases of cervical cancer in the United States with 4,000 deaths annually. Which statement is true:

Disease staging including lymph node involvement are the most valuable prognostic factors and guide therapeutic options.

HPV is detected in 99.7% of squamous and adenocarcinomas of the cervix.

Use of adjuvant platinum-based chemo-radiation after surgery for early cervical cancer (stage IA2 to IIA) with risk factors for recurrence reduces mortality.

All the above.